Licensing Agreement with Kimberly-Clark

RNS Number : 8357J
Byotrol PLC
13 August 2012
 



 

 

 

For Immediate Release                                                                                             13 August 2012

 

 

Byotrol plc Licensing Agreement with

Kimberly-Clark Corporation

 

The Board of Byotrol plc ('Byotrol' or 'the Company'), the leading AIM listed anti-microbial hygiene company is delighted to provide an update on its agreement with its Fortune 150 partner, Kimberly-Clark Corporation (Kimberly-Clark).

 

Byotrol Consumer Products (BCP), Byotrol's 50% owned consumer products subsidiary, and Kimberly-Clark have agreed to enter into a full licensing agreement (Agreement). Details of the Agreement are not being disclosed at this time.

 

The Agreement between BCP and Kimberly-Clark follows the successful completion of the initial Joint Development Agreement with a Fortune 150 partner Byotrol announced on 31 January 2012. The new, seven-year contract is global in scope, with some exceptions including certain EU markets, and provides Kimberly-Clark exclusive intellectual property rights.

 

Kimberly-Clark and its well-known global brands are an indispensable part of life for people in more than 175 countries. Every day, nearly a quarter of the world's population trust K-C's brands and the solutions they provide to enhance their health, hygiene and well-being. With brands such as Kleenex, Scott, Huggies, Pull-Ups, Kotex and Depend, Kimberly-Clark holds the No. 1 or No. 2 share position in more than 80 countries.

 

 

Commenting on the commercial agreement, Ralph Kugler, Chairman at Byotrol, said:

 

 "This is a landmark agreement for Byotrol.  It realises a central tenet of our strategy by partnering with a global consumer-focussed company.

 

"We are delighted to have worked so closely with a company as respected as Kimberly-Clark in arriving at this significant result, and we appreciate the commitment to Byotrol that Kimberly-Clark has shown from the earliest stage.  The agreement also reflects the outstanding effort made by our partners at BCP."

 

 

Gary Millar, Chief Executive at Byotrol, added:

 

"The successful conclusion of the initial phase of the relationship with Kimberly-Clark is a considerable endorsement of the Byotrol technology.

 

"This collaboration has been a significant step in developing Byotrol technology and we see this as a starting point to explore further potential. 

 

"Byotrol technology offers a unique advantage in the highly competitive global hygiene market.  We are confident that this distinguishing quality will make Byotrol a market leader."

 

Jon Wilson, Vice President, Corporate Innovation for Kimberly-Clark, added:

 

"Delivering to market game-changing innovations is a critical element to achieving Kimberly-Clark's vision of leading the world in essentials for a better life. Key to achieving this is the creation of an innovative culture at Kimberly-Clark that fosters win-win opportunities between our organization and external partners, such as Byotrol.

 

"Innovation is a race without a finish line. We must continually incorporate new technologies, leverage fresh understandings of the consumer and find new ways to win in the marketplace. Having strategic partners, like a Byotrol, is core to Kimberly-Clark's innovation journey."

 

 

Enquiries:

 

Byotrol plc

01925 742000

Ralph Kugler, Chairman

 

Gary Millar, Chief Executive

 

Duncan Grosvenor, Finance Director

 

 

 

finnCap Limited

020 7220 0500

Nominated Adviser and broker

 

Geoff Nash/Christopher Raggett

Simon Starr (Corporate Broking)

 

 

 

Winningtons

020 3176 4722

Tom Cooper / Paul Vann

07768 807 631

 

paul.vann@winningtons.co.uk

 

 

Notes to Editors:

 

Byotrol plc (BYOT.L), quoted on AIM, is a leading anti-microbial technology hygiene company, operating globally in the Health, Food, Leisure, Consumer, Industrial and Agriculture sectors, providing a low toxicity product with a broad-based and long lasting efficacy across all microbial classes; bacteria, viruses, fungi, moulds, microbacteria and algae.

 

The Byotrol product can be used as a stand alone product or as a complementary biocide additive to existing products to improve their performance in personal hygiene, domestic and industrial disinfection, odour control, food production and food management.

 

Founded in 2005, the Company has prioritised the development of a technology that creates easier, safer and cleaner lives through partnering with providers of essential goods and services.  Byotrol is the catalyst behind the aptly named global 'Hygiene Revolution'.


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGRPTMJTMBTBTJT

Companies

Byotrol (BYOT)
UK 100

Latest directors dealings